Back to Journals » Therapeutics and Clinical Risk Management » Volume 8
Original Research
Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
13,373 | Dovepress* | 10,665+ | 1,584 | 12,249 | |
PubMed Central* | 2,708 | 390 | 3,098 | ||
Totals | 13,373 | 1,974 | 15,347 | ||
*Since 20 June 2012 +Since July 2016 |
View citations on PubMed Central and Google Scholar